BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 24767875)

  • 1. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
    Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
    Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
    Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge.
    Bochenek G; Nagraba K; Nizankowska E; Szczeklik A
    J Allergy Clin Immunol; 2003 Apr; 111(4):743-9. PubMed ID: 12704352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
    Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
    J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
    Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
    Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease.
    Woessner KM; White AA
    J Allergy Clin Immunol; 2014 Jan; 133(1):286-7.e1-9. PubMed ID: 24369807
    [No Abstract]   [Full Text] [Related]  

  • 11. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CXCL10 expression in nasal fibroblasts from patients with refractory chronic rhinosinusitis and asthma.
    Yoshikawa M; Wada K; Yoshimura T; Asaka D; Okada N; Matsumoto K; Moriyama H
    Allergol Int; 2013 Dec; 62(4):495-502. PubMed ID: 24153332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
    Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
    Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
    Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
    Front Immunol; 2021; 12():695815. PubMed ID: 34305932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls.
    Micheletto C; Visconti M; Tognella S; Facchini FM; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):20-3. PubMed ID: 16544584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triad.
    Mardiney M; Borish L
    Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1287. PubMed ID: 11587618
    [No Abstract]   [Full Text] [Related]  

  • 18. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aspirin desensitization indicated for the treatment recalcitrant chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease?
    Levy JM; Smith TL
    Laryngoscope; 2017 Apr; 127(4):776-777. PubMed ID: 27813100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.